|
03 Apr 2019 |
Tetraphase Pharmaceuticals Presents Preclinical Data on TP-2846, a Novel Drug Candidate for Acute Myeloid Leukemia
|
|
03 Apr 2019 |
Rgenix Presents Pre-Clinical Data on RGX-019 at the 2019 AACR Annual Meeting
|
|
03 Apr 2019 |
Sierra Reports Late-Breaking SRA141 Preclinical Data in Poster at AACR 2019
|
|
03 Apr 2019 |
Dynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual Meeting
|
|
03 Apr 2019 |
Alligator Bioscience: New preclinical data for ATOR-1144 demonstrate potential for activation of both the innate and the adaptive immune system, as well as direct anti-tumor effects
|
|
03 Apr 2019 |
Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms
|
|
03 Apr 2019 |
Pieris Pharmaceuticals Presents Preclinical Data for GPC3/4-1BB Bispecific PRS-342 at the 2019 American Association for Cancer Research
|
|
03 Apr 2019 |
Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting
|
|
03 Apr 2019 |
Inovio Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi-specific T Cell Engagers (dBiTEs) at AACR
|
|
03 Apr 2019 |
Leaps by Bayer and Khloris join forces to develop induced pluripotent stem cells (iPSCs) as breakthrough anti-cancer vaccines
|
|
03 Apr 2019 |
Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol
|
|
03 Apr 2019 |
Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data
|
|
03 Apr 2019 |
Sangamo and Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy
|
|
03 Apr 2019 |
Sandoz resubmits biosimilar pegfilgrastim application to US FDA
|
|
02 Apr 2019 |
Celldex Presents Positive Interim Results from Phase 1 Study of CD40 Agonist CDX-1140 at American Association for Cancer Research (AACR) Annual Meeting 2019
|
|
02 Apr 2019 |
Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
|
|
02 Apr 2019 |
Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial
|
|
02 Apr 2019 |
Apexigen Presents Clinical Data On CD40 Antibody APX005M In Metastatic Melanoma At The AACR Annual Meeting 2019
|
|
02 Apr 2019 |
IO Biotech Presents Data on an Immunomodulatory CCL22-based Vaccine at the American Association for Cancer Research Annual Meeting 2019
|
|
02 Apr 2019 |
Nordic Nanovector: Promising Results From Preclinical Studies With a Novel CD37-targeted Alpha Therapy for B-cell Tumours Presented at TAT11
|
